(Q34240998)

31 July 2017

1 reference

title

Clinical review of glimepiride (English)

1 reference

31 July 2017

McCall AL

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

Expert Opinion on Pharmacotherapy

31 July 2017

published in

1 reference

31 July 2017

volume

2

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

699-713

1 reference

Metabolic and adipose risk factors for NIDDM and coronary disease in third-generation Japanese-American men and women with impaired glucose tolerance.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.699

Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.699

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.699

ATP-sensitive K+ channels and insulin secretion: their role in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.699

Glimepiride: role of a new sulfonylurea in the treatment of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.699

The Achilles heel of the University Group Diabetes Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.699

Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.699

Comparison of the efficacy of glibenclamide and glimepiride in reperfusion-induced arrhythmias in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.699

Rates of hypoglycemia in users of sulfonylureas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.699

Pharmacokinetics and safety of glimepiride at clinically effective doses in diabetic patients with renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.699

The use of sulphonylureas in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.699

A placebo-controlled, randomized study of glimepiride in patients with type 2 diabetes mellitus for whom diet therapy is unsuccessful

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.699

21 January 2018

Evening insulin strategy

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.699

Combined insulin and sulfonylurea therapy for type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.699

21 January 2018

Oral hypoglycemic agents

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.699

Altered Hierarchy of Protective Responses Against Severe Hypoglycemia in Normal Aging in Healthy Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.699

21 January 2018

Identifiers

DOI

10.1517/14656566.2.4.699

1 reference

31 July 2017

1 reference